Cosmo Pharmaceuticals N.V. (ETR:C43)
58.00
+0.50 (0.87%)
Last updated: Mar 27, 2025
Cosmo Pharmaceuticals Revenue
In the year 2024, Cosmo Pharmaceuticals had annual revenue of 266.79M EUR with 187.55% growth. Cosmo Pharmaceuticals had revenue of 130.55M in the half year ending December 31, 2024, with 115.51% growth.
Revenue
266.79M
Revenue Growth
+187.55%
P/S Ratio
n/a
Revenue / Employee
828.53K
Employees
322
Market Cap
961.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 266.79M | 174.01M | 187.55% |
Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
Dec 31, 2020 | 60.95M | -1.55M | -2.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 34.18B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 9.75B |
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |